Jpmorgan Chase & CO My Md Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.22 - $0.58 $4,130 - $10,890	18,776 Added 44704.76%	18,818 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.47 - $1.87 $19 - $78	42 New	42 $0
Q1 2023 May 11, 2023	BUY	$1.1 - $2.86 $381 - $992	347 New	347 $0
Q1 2022 May 11, 2022	SELL	$3.34 - $6.05 $29,839 - $54,050	-8,934 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.46 - $9.69 $48,779 - $86,570	8,934 New	8,934 $54,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.